Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 1,699 | 1,942 | 1,225 | 1,101 | 1,704 |
| Operating Income | -1,699 | -1,942 | -1,225 | -1,101 | -1,704 |
| Interest Expense | 5 | -22 | 1 | 0 | 0 |
| Other Income | 0 | -31 | 2 | 20 | 9 |
| Pre-tax Income | -1,704 | -1,951 | -1,224 | -1,081 | -1,695 |
| Net Income Continuous | -1,704 | -1,951 | -1,224 | -1,081 | -1,695 |
| Net Income | $-1,704 | $-1,951 | $-1,224 | $-1,081 | $-1,695 |
| EPS Basic Total Ops | -0.88 | -1.12 | -0.72 | -0.64 | -1.04 |
| EPS Basic Continuous Ops | -0.87 | -1.07 | -0.70 | -0.67 | -1.05 |
| EPS Diluted Total Ops | -0.88 | -1.12 | -0.72 | -0.64 | -1.04 |
| EPS Diluted Continuous Ops | -0.87 | -1.07 | -0.70 | -0.67 | -1.05 |
| EBITDA(a) | $-1,692 | $-1,936 | $-1,217 | $-1,096 | $-1,699 |